OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.

Slides:



Advertisements
Similar presentations
Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Advertisements

Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
The Scale, Causes and Costs of Medicines Waste – a national perspective Northamptonshire Medicine Waste Management Conference, 28 th November 2012 David.
Walsall Healthcare NHS Trust Medicines Management.
Disease State Management The Pharmacist’s Role
THE INAPPROPRIATE SALE OF MEDICATION FOR PEDIATRIC USE IN SIEM REAP PROVINCE, KINGDOM OF CAMBODIA AUTHORS: Sothearith Tiv Ph., Rathi Guhadasan MBBS MRCP.
The Value of Medication Therapy Management Services
The challenge of medicines non-adherence. 2 How is adherence defined? WHO definition: ‘the extent to which a person’s behaviour – taking medication, following.
Drug Utilization Review (DUR)
The Challenges for Medicines Optimisation
Basma Y. Kentab MSc. Department of Clinical Pharmacy May 2014.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
WELCOME EXPERIENCE PHARMACY AT KING’S. Timetable 12:00Introduction 12:15Mini-lectures: Medicines Optimisation |The Science Perspective |The Clinical Perspective.
Dementia Master Class Dr Helen Martin Dr Harry Allen.
Discharge planning – reducing admissions/re- admissions Jo Clarke, CPPE tutor 1.
Polypharmacy and Adverse Drug Reactions (ADR) in the Elderly
Knowledge Driven Care – Realised Through Transformation Dr Simon Wallace Medical Executive Cerner UK.
HRET/K-HEN Readmissions Race Office Hour Building a Multidisciplinary Care Transitions Team January 25, 2013.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Research methods: answering questions.
The Pharmaceutical Care of Patients with Long Term Conditions Deirdre Watt Team Leader, Community Pharmacy Scottish Government.
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Fundamental question What patient-specific information do I need to provide pharmaceutical care? What is the most reliable & efficient way to get it?
Pharmaceutical Economics Heng-Sim Lee RPh MS Director of Pharmacy, ChiaYi Branch, Taichung Veterans General Hospital Clinical Nutritional.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
The Value of Medication Therapy Management Services.
EPIC – a Chronic Disease Management Initiative in BC Barbara Ogle, BSc(Pharm), ACPR, MScPhm, RPh VP Clinical Services, Network Healthcare May 31, 2007.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Background Collection of S & O Information Data: – CC, HPI, PMH, PSHx, Demographics – Medication history including compliance etc. – VS, ROS, Lab, other.
PHCL 436 Lecture two. Objectives  The role of cognition in influencing adjustment to chronic conditions  What is medication adherence, prevalence, reasons,
Medication Safety and admissions avoidance: A perspective Steve Williams Consultant Pharmacist in Medicine & Medication Safety Honorary Clinical Lecturer,
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 2 Application of Pharmacology in Nursing Practice.
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.
Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene.
Care Experience Breakout Sessions Trudi Marshall
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
Introduction.
Pharmacovigilance WHO definition
Single Competency Framework for Prescribers National Prescribing Centre (2012)
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
Better Patient Adherence: Why patients don’t adhere and what we can do about it (maybe) Frank Doyle, PhD RCSI Royal College of Surgeons in Ireland Coláiste.
Pharmaceutical Society of Ireland – The Pharmacy Regulator The Role of the Pharmacist in Self Care Telephone: Shrewsbury Rd Fax:
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
Medication therapy management
The challenge of medicines
Hypertension November 2016
PHARMACIST : A HEALTH CARE PROFESSIONAL
Clinical Pharmacy II.
Introduction to Clinical Pharmacy
Medication Safety Dr. Kanar Hidayat
Victoria Gemmell1 Professor Alex Mullen2
Pharmacy practice experience I
Medicines Safety Programme
Pharmaceutical care planning 2 Ola Ali Nassr
Medication Safety Dr. Kanar Hidayat
Value Based Healthcare King’s Health Partners
Pharmaceutical care plans Ola Ali Nassr
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Presentation transcript:

OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London

Learning outcomes 1.Describe the problems commonly associated with the use of medicines 2.Explore the common causes of adverse drug reactions 3.Describe how pharmacists can contribute to optimising medicines use

Typical patient journey PatientExperiences Symptoms or routine health check Diagnosis Seek health care Intervention (referral, procedure or medicine)

Medicines: the most common intervention NHS Budget: 1999/2000£40 billion £105 billion Drug Expenditure 15% of budget

Medicines in perspective Explosion of anti-infective agents to target range of infections e.g. range of antibiotics; HIV Positive impact of low dose aspirin on mortality following a heart attack (1980s) The significant benefit of ACE Inhibitors to treat heart failure (1987) Impact of statins to control blood cholesterol (1990s) Expansion in the range of chemotherapy agents

Evidence based treatment

“ One of the greatest hazards is the use of potent drugs is their inherent toxicity…… …..the dangers of the drug appear to be greater now then ever before.” David Barr MD; Hazards of modern diagnosis and therapy – the price we pay. Frank Billings Memorial Lecture. J Am Med Assoc 1955;159 (15):

Problems caused by medicines

Adverse drug reactions causing hospital admission 1.6.5% of all admissions due to an ADR 2.Elderly patients 3-4 times more likely to be admitted with ADR 3.4% of hospital bed capacity % fatality 5.Drug-interactions responsible for 1 in 6 ADRs 6.72% were preventable 7.Cost to NHS £466 million/year Pirmohamed, M., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of patients. BMJ, (7456): 15-9.

Adverse drug reactions and the elderly Tangiisuran et al Drugs in Aging 2012

Which medicines cause harm? Safety in Doses. National Patient Safety Agency 2009

Non-adherence to medicines 1 World Health Organization Report Horne et al. Concordance, adherence and compliance in medicine taking. NIHR SDO NICE. Medicines concordance & adherence: involving adults and carers in decisions about prescribed medicines 2008/9 Recent reports: Estimated that between % medicines prescribed for long term illnesses are not taken as directed. Cost associated with wastage – not only the medicine but the time of healthcare staff.

Sources of medication problems - multifactorial Prescribing - selecting the wrong or inappropriate drug, often at the wrong dose for the patient, Co-prescribing – interacting medicines, complementary therapy or alcohol Lack of patient education - information relating to: –What do they understand about their disease? –Do they understand the benefits of therapy? –What concerns do they have about their prescribed medicines?

ROLE OF PHARMACISTS IN MANAGING MEDICINES

Pharmacists – optimising medicines use

Identifying medication problems Knowledge of patient – is there anything about this patient that concerns me? Knowledge of medicine – is there anything about this medicine that concerns me?

Patient factors Patient Characteristics –Age, ethnicity, gender –Height, weight, BMI –Pregnancy & breast feeding Co-morbidities (for example) –Asthma and hypertension –Arthritis and peptic ulcer disease –Allergy status and infection –Pain and renal disease Function and cognitive factors –Mobility, balance, sight, swallowing –Memory, comprehension Social and environmental factors –Lifestyle, home environment and family support –Support services available Patient’s perception of drug therapy

Medicine factors Toxicity Factors –Drug interactions, complementary medicines, –Allergy status, contraindications, –Adverse reaction profile –Therapeutic index of medicine Drug factors –Renal and hepatic function Evidence of efficacy supporting medicine Response to current and previous drug therapy –Did the treatment work? –Did the patient experience any problems?

The care process Establishing a therapeutic relationship - a continuous process PATIENT ASSESSME NT CARE PLAN EVALUATIO N

Use a range of information to: Identify actual and potential drug related problems Resolve actual drug related problems Prevent potential drug related problems

Summary Medicines are beneficial but can also cause harm Society needs a gatekeeper who manages medicines for society - seen as the drug expert - the pharmacist Pharmacists must adopt a patient focused approach to identifying and resolving medication related issues Understanding the aims and process which underpin the process of identifying medication - related problems is essential to delivering safe and effective care

OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London